Lv6
1910 积分 2021-07-14 加入
Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine
5小时前
待确认
Letter by Xu et al Regarding Article, “Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial”
29天前
已完结
Coronary microvascular dysfunction
2个月前
已完结
Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies
3个月前
已完结
The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk
4个月前
已完结
Serum glycolipids mediate the link between dietary antioxidants and mortality in metabolic syndrome
5个月前
已完结
Unveiling the Mimickers: A Call to Reassess MINOCA Diagnostic Criteria
7个月前
已完结
Effectiveness of sodium-glucose co-transporter 2 inhibitors on atrial fibrillation recurrence after catheter ablation: A systemic review and meta-analysis
7个月前
已完结
Off-Label Dapagliflozin After Atrial Fibrillation Ablation: A Reasonable Intervention or Overstretching the Evidence?
7个月前
已完结
Association between C-reactive protein-triglyceride glucose index (CTI) and cardiovascular and all-cause mortality risk among the elderly population: insights from three datasets
8个月前
已完结
皖公网安备34019202002308
